For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow gems #76
Wednesday 11 April 2018, 02:00 AM

“Triple whammy of ACE/ARB + diuretic + NSAID – a dangerous trio”
The common combination of medication – angiotensin converting enzyme inhibitor/ angiotensin II receptor blocker (ACE/ARB), diuretic and nonsteroidal a
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.